Cancer screening: Study challenges whether six common tests save lives
A meta-analysis of six common cancer screenings has concluded that “current evidence does not substantiate the claim that common cancer screening tests save lives by extending lifetime, except possibly for colorectal cancer screening with sigmoidoscopy.” Michael Bretthauer and colleagues from the University of Oslo reported in JAMA Internal Medicine that screening benefits were small: a statistically significant 110 days’ gain was seen with colorectal cancer screening with sigmoidoscopy.1 Gains were 37 days with prostate cancer screening and colonoscopy and 107 days with lung cancer scre...
Source: bmj.com
